Remdesivir therapy for severe pediatric COVID-19 in Singapore: a single-center retrospective observational cohort study
There is a paucity of information on remdesivir (RDV) use in severe pediatric coronavirus disease 2019 (COVID-19). We aimed to explore the effectiveness of RDV as the cumulative proportion of pediatric COVID-19 patients deescalated from Day 5 of high dependency or intensive care unit (HD/ICU).
Váldodahkkit: | , , , , , , , , |
---|---|
Eará dahkkit: | |
Materiálatiipa: | Journal Article |
Giella: | English |
Almmustuhtton: |
2024
|
Fáttát: | |
Liŋkkat: | https://hdl.handle.net/10356/173749 |